Henry Schein, Inc. (NASDAQ:HSIC) Given Average Recommendation of “Moderate Buy” by Brokerages

by · The Markets Daily

Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $79.30.

HSIC has been the subject of a number of recent research reports. Piper Sandler reduced their price objective on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research note on Wednesday, April 30th. UBS Group cut their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Barrington Research cut their target price on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday, May 6th. StockNews.com downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Finally, Wells Fargo & Company cut their target price on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th.

Get Our Latest Analysis on Henry Schein

Henry Schein Trading Up 1.8%

Henry Schein stock opened at $73.13 on Friday. The firm has a 50-day moving average of $67.44 and a 200-day moving average of $71.49. Henry Schein has a one year low of $60.56 and a one year high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market cap of $8.90 billion, a price-to-earnings ratio of 30.09, a P/E/G ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the prior year, the business posted $1.10 EPS. The company’s quarterly revenue was down .1% on a year-over-year basis. On average, equities analysts expect that Henry Schein will post 4.74 earnings per share for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.08% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in HSIC. Focus Partners Wealth boosted its position in shares of Henry Schein by 1.8% during the 1st quarter. Focus Partners Wealth now owns 32,241 shares of the company’s stock worth $2,208,000 after acquiring an additional 560 shares in the last quarter. Bayforest Capital Ltd acquired a new stake in shares of Henry Schein during the 1st quarter worth approximately $103,000. MBB Public Markets I LLC acquired a new stake in shares of Henry Schein during the 1st quarter worth approximately $308,000. Great Lakes Advisors LLC acquired a new stake in shares of Henry Schein during the 1st quarter worth approximately $4,477,000. Finally, Clearline Capital LP acquired a new stake in shares of Henry Schein during the 1st quarter worth approximately $16,095,000. 96.62% of the stock is owned by institutional investors.

About Henry Schein

(Get Free Report

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More